<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00269425</url>
  </required_header>
  <id_info>
    <org_study_id>THIS-A20010724157261</org_study_id>
    <nct_id>NCT00269425</nct_id>
  </id_info>
  <brief_title>The Heart Institute of Spokane Diet Study</brief_title>
  <official_title>The Heart Institute of Spokane Diet Intervention and Evaluation Trial (THIS DIET)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Providence Health &amp; Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Heart Institute of Spokane</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Providence Medical Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Washington State Attorney General's Office</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Deaconess Medical Center, Spokane, Washington</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Providence Health &amp; Services</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a Mediterranean style diet, enriched in&#xD;
      monounsaturated and omega-3 fats, is superior to the American Heart Association Step 2 diet,&#xD;
      a traditional low fat diet, for improving rates of survival and cardiovascular complications&#xD;
      in persons who have had a first myocardial infarction (heart attack).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiovascular diseases (heart attack, stroke, and other vascular diseases) are major causes&#xD;
      of mortality in developed countries. Although medicines and revascularization procedures&#xD;
      prolong lives, rates of death and disability remain high. Lifestyle factors greatly&#xD;
      contribute to risk. Yet, scientific data regarding the role of lifestyle change in prevention&#xD;
      and treatment are limited. In the nutrition area, limitations include observational or&#xD;
      uncontrolled study design, and focus on surrogate markers rather than on clinical outcomes.&#xD;
&#xD;
      Excess dietary fat has long been associated with cardiovascular diseases. Increased risk is&#xD;
      related both to types of fat and calories from fat. Saturated fat, cholesterol, and&#xD;
      trans-fatty acids have all been associated with adverse outcomes. Because fat is&#xD;
      calorie-laden, high fat diets are commonly associated with weight gain and obesity. Low-fat&#xD;
      diets have traditionally been recommended to control lipids and weight. However, these diets&#xD;
      are high in carbohydrate and may actually be associated with weight gain if calories are not&#xD;
      limited. Such diets have also been associated with worsening of hyperinsulinemia and insulin&#xD;
      resistance and an adverse lipid pattern (low HDL cholesterol and high triglyceride levels).&#xD;
      In contrast, increased intake of monounsaturated and omega-3 fats is associated with&#xD;
      favorable effects on cardiovascular risk factors and markers including: endothelial function,&#xD;
      lipids, and levels of insulin and glucose. Results have been consistent across various groups&#xD;
      of high-risk patients, including those with hypercholesterolemia, diabetes, and hypertension.&#xD;
      Most importantly, a Mediterranean style diet enriched in monounsaturated and omega-3 fats&#xD;
      reduced death and cardiovascular complications after myocardial infarction (MI) in the Lyon&#xD;
      Heart study.&#xD;
&#xD;
      The American Heart Association (AHA) Step 2 is a low-fat diet traditionally recommended for&#xD;
      people with cardiovascular disease. The Mediterranean and AHA Step 2 diets differ primarily&#xD;
      in the amount of monounsaturated and omega-3 fats, both of which are higher in the&#xD;
      Mediterranean diet. Both diets are low in saturated fat (less than 7%) and cholesterol (less&#xD;
      than 200 mg/d). Although the Lyon Heart Study compared a Mediterranean diet to a &quot;prudent&#xD;
      Western diet,&quot; a low fat diet similar to the AHA diet, the latter group did not achieve&#xD;
      recommended intake levels of saturated fat or cholesterol. Furthermore, there was no&#xD;
      longitudinal nutritional intervention in the low fat diet group. Therefore, the effect of&#xD;
      nutritional intervention per se was not addressed.&#xD;
&#xD;
      Comparison(s): In survivors of a first MI, two longitudinal nutritional interventions, a&#xD;
      Mediterranean style diet and an AHA Step 2 diet, will be compared. Both intervention groups&#xD;
      will be compared to an untreated control group from our clinical database.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2000</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fatal/non-fatal myocardial infarction</measure>
    <time_frame>3,6,12,18,24,36,48,60,72 months</time_frame>
    <description>The primary outcome was a composite of end points including all-cause and cardiac deaths, MI, hospital admissions for heart failure, unstable angina, or stroke.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular death</measure>
    <time_frame>3,6,12,18,24,36,48,60,72 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Non-cardiovascular death</measure>
    <time_frame>3,6,12,18,24,36,48,60,72 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroke/TIA</measure>
    <time_frame>3,6,12,18,24,36,48,60,72 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Admission for congestive heart failure or unstable angina</measure>
    <time_frame>3,6,12,18,24,36,48,60,72 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular revascularization</measure>
    <time_frame>3,6,12,18,24,36,48,60,72 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral revascularization or amputation</measure>
    <time_frame>3,6,12,18,24,36,48,60,72 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Doubling of serum creatinine,dialysis,or kidney transplant</measure>
    <time_frame>3,6,12,18,24,36,48,60,72 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New hypertension</measure>
    <time_frame>3,6,12,18,24,36,48,60,72 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New diabetes</measure>
    <time_frame>3,6,12,18,24,36,48,60,72 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk factors (traditional and novel)</measure>
    <time_frame>3,6,12,18,24,36,48,60,72 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">202</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Mediterranean diet,</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>American Heart Association Step 2 diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Case controlled</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>American Heart Association Step 2 diet</intervention_name>
    <description>Low fat diet with patient education and diet analysis</description>
    <arm_group_label>American Heart Association Step 2 diet</arm_group_label>
    <other_name>Low fat diet</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mediterranean diet</intervention_name>
    <description>Mediterranean style diet with patient education and diet analysis</description>
    <arm_group_label>Mediterranean diet,</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  First myocardial infarction&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior myocardial infarction&#xD;
&#xD;
          -  Uncontrolled or secondary hypertension&#xD;
&#xD;
          -  New York Heart Association heart failure stage III or IV&#xD;
&#xD;
          -  Ventricular arrythmias requiring medical or defibrillatory intervention&#xD;
&#xD;
          -  Other diseases that may make study completion difficult or unlikely&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katherine R. Tuttle, MD,FASN,FACP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Providence Medical Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Providence Medical Research Center</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2005</verification_date>
  <study_first_submitted>December 22, 2005</study_first_submitted>
  <study_first_submitted_qc>December 22, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2005</study_first_posted>
  <last_update_submitted>August 23, 2010</last_update_submitted>
  <last_update_submitted_qc>August 23, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 24, 2010</last_update_posted>
  <responsible_party>
    <name_title>Katherine R. Tuttle, MD</name_title>
    <organization>Providence Medical Research Center</organization>
  </responsible_party>
  <keyword>Cardiovascular disease</keyword>
  <keyword>Nutrition</keyword>
  <keyword>Mediterranean diet</keyword>
  <keyword>Low fat diet</keyword>
  <keyword>American Heart Association diet</keyword>
  <keyword>Monounsaturated fats</keyword>
  <keyword>Omega-3 fats</keyword>
  <keyword>Outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

